Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A concise volatility overview comparing balanced funds and the SP 500 during retirement, with implications for risk management.
24,544 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Shareholders allege a controlling investor pressured Red Lobster to endure an endless shrimp push, turning a popular ...
Investors face a clear choice between two CRM juggernauts. This guide breaks down HubSpot and Salesforce, weighing gr...
XRP trades near $1.05 as on-chain MVRV metrics flash a rare setup. A breakout above stubborn resistance could unlock ...
When a high-profile investor makes a big move, questions follow. This guide cuts through the headlines to examine Ali...
A growing share of CFOs now oversee strategic planning, signaling a shift in how companies allocate capital and pursu...
Trump endorses Mike Lindell as Minnesota governor candidate, highlighting election-security themes and setting up a h...
Mark Cuban is reviving the debate over wage inequality by urging companies to grant stock to every worker. His pitch ...
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...
On a day of mixed signals, Bank of America and peers moved as tariffs and earnings chatter swirled. This article brea...
As Camping World gears up for 2025, investors want clarity on growth, margins, and capital allocation. This analysis ...